Ticker Details
Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
IPO Date:	May 1, 2007
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$142.37M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 2.97%
Avg Daily Range (30 D):	$0.08 | 2.23%
Avg Daily Range (90 D):	$0.08 | 2.46%

Institutional Daily Volume
Avg Daily Volume:	.25M
Avg Daily Volume (30 D):	.11M
Avg Daily Volume (90 D):	.16M

Trade Size
Avg Trade Size (Sh.):	158
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	132

Institutional Trades
Total Institutional Trades:	115
Avg Institutional Trade:	$1.68M
Avg Institutional Trade (30 D):	$4.62M
Avg Institutional Trade (90 D):	$4.62M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.39M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	297.23K

News

Mar 13, 2026 @ 12:00 PM Lifeward Receives Shareholder Approval to Close on... Source: Na

Jan 7, 2026 @ 1:55 PM Oramed Receives $18 Million Payment from Scilex Ho... Source: Prnewswire

Nov 17, 2025 @ 1:50 PM ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DIST... Source: Prnewswire

Feb 11, 2025 @ 2:15 PM Oramed Announces Transformative Joint Venture to A... Source: Prnewswire

Feb 2, 2024 @ 1:21 PM Top 4 Health Care Stocks That May Crash This Quart... Source: Avi Kapoor

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.53	$.23	$1.53
Diluted EPS	$1.5	$.24	$1.5
Revenue	$2M	$M	$2M
Gross Profit	$.01M	$M	$.01M
Net Income / Loss	$64.02M	$10.01M	$64.02M
Operating Income / Loss	$-15.09M	$-5.67M	$-15.09M
Cost of Revenue	$1.99M	$M	$1.99M
Net Cash Flow	$-8.47M	$-6.23M	$-8.47M
PE Ratio	2.35

Splits
Jan 23, 2013	1:12